Stratum Biosciences Raises $2M Seed To Scale Platform
Stratum Biosciences, a New York biotechnology startup focused on AI-driven dermatology research, announced it closed a $2 million seed round backed by the Harvard Business School Alumni Angels of Greater New York and Skin Angels. Founded in 2024 by Dr. Ross Lane Pearlman and Dr. Buu Duong, the company will use the investment to scale its AI-powered skin biology discovery platform mining over 200,000 real skin samples to accelerate product development.
Key Points
- 1Secures $2M seed from Harvard Business School Alumni Angels and Skin Angels investors.
- 2Expands AI-powered skin biology platform mining over 200,000 real skin samples for novel insights.
- 3Provides dermatology researchers and product teams with data-driven discovery and accelerated development capabilities.
Scoring Rationale
Official seed funding announcement provides credible, actionable startup news, but limited novelty and niche scope reduce broader impact.
Sources
Public references used for this report.
Practice interview problems based on real data
1,625 SQL & Python problems across 15 industry datasets — the exact type of data you work with.
Try 250 free problems
